Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

NCT05271292 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer
Advanced Solid Malignant Tumor

Interventions

DRUG: Chiauranib

Sponsor

Chipscreen Biosciences, Ltd.